The DOI matches its Crossref record; 110 of the 114 references it cites were found in a registry or an index.
Hypopituitarism
Abstract
Incidence and prevalence of hypopituitarism are estimated to be 4.2 per 100,000 per year and 45.5 per 100,000, respectively. Although the clinical symptoms of this disorder are usually unspecific, it can cause life-threatening events and lead to increased mortality. Current research has refined the diagnosis of hypopituitarism. Identification of growth hormone and corticotropin deficiency generally requires a stimulation test, whereas other deficiencies can be detected by basal hormones in combination with clinical judgment. Newly developed formulations of replacement hormones are convenient and physiological. Work has shown that many patients with brain damage--such as traumatic brain injury or aneurysmal subarachnoid haemorrhage--are at high risk of (sometimes unrecognised) hypopituitarism. Thus, a much increased true prevalence of this disorder needs to be assumed. As a result, hypopituitarism is not a rare disease and should be recognised by the general practitioner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diagnosis of TBI-induced hypopituitarism, defined as the deficient hormone secretion of one or more pituitary hormones because of TBI, is made similarly to the diagnosis of classical hypopituitarism because of hypothalamic or pituitary diseases.”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [194]
In the citing paper
“Each pituitary hormone must be tested separately because there is a variable pattern of hormone deficiency among patients with TBI-induced hy-popituitarism (194).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [194]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [194]
In the citing paper
“In TBI patients, secondary adrenal insufficiency can be excluded at morning cortisol levels greater than 500 nmol/L (Ͼ18 g/dL) and is indicated below 83-100 nmol/L (Ͻ3 g/dL).Levels in between require a stimulation test (194, 199 -201).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [194]
In the citing paper
“Differences in the reported frequency of TBI-induced hypopituitarism may be due to more stringent diagnostic criteria being applied by some studies but not by others (21,194).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [194]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
A systematic review of brain injury epidemiology in Europe
Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., & Kraus, J. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-005-0651-y · Cited by 1,223
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Alexander, E. K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G. A., & Larsen, P. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040079 · Cited by 633
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
Research works printed but not linked: 3
- 1998, No authors listed. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency, J Clin Endocrinol Metab, 83, 379
- Ten, 2001, Clinical review 130: Addison's disease 2001, J Clin Endocrinol Metab, 86, 2909
- Moore, 1999, Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies, J Clin Endocrinol Metab, 84, 4172
Cited by
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Self-citationLoss of hypocretin (orexin) neurons with traumatic brain injury
Baumann, C. R., Bassetti, C. L., Valko, P. O., Haybaeck, J., Keller, M., Clark, E., Stocker, R., Tolnay, M., & Scammell, T. E. (2009) · Annals of Neurology · doi:10.1002/ana.21836 · Cited by 195
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
New evidence suggesting a dissociated etiology for cribra orbitalia and porotic hyperostosis
Rivera, F., & Lahr, M. M. (2017) · American Journal of Physical Anthropology · doi:10.1002/ajpa.23258 · Cited by 165
Metadata
- Authors
- Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Turin (IT)
- Corresponding author
- Schneider, Harald Jörn
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 369
- Issue
- 9571
- Pages
- 1461-1470
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4211015768
- Semantic Scholar
- c2dabc354c94038ef140b0115d554abc14fe2bea
- Cited by
- 336
- References
- 114
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 20 · 2022: 9 · 2021: 18 · 2020: 17 · 2019: 14 · 2018: 16 · 2017: 21 · 2016: 22 · 2015: 23 · 2014: 22 · 2013: 22 · 2012: 29
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Torino
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypopituitarism, incidence, prevalence, mortality, growth hormone deficiency, corticotropin deficiency, stimulation tests, hormone replacement therapy, traumatic brain injury, aneurysmal subarachnoid hemorrhage, brain damage
- MeSH terms
- Adrenocorticotropic Hormone, Brain Injuries, Female, Humans, Hypopituitarism, Luteinizing Hormone, Magnetic Resonance Imaging, Male, Pituitary Gland, Testosterone, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypopituitarism. https://app.cochat.ai/papers/10.1016/s0140-6736(07)60673-4
- The paper
- Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007). Hypopituitarism. The Lancet. https://doi.org/10.1016/s0140-6736(07)60673-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.